Cases - Business

Factoring software can be defined as an interacting, continuing, future-oriented structure of eq

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

uipment and procedure, designed to generate and process information flow that can aid business e

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

xecutives in the management of their programs.

Factoring software involves broader and more inc

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

lusive activity then, say, research. It includes determining and specifying the data needed, th

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

e generation of this information by means of research then the processing of this data. While t

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

his is a system concept, research usually deals with fragmented, unrelated research projects, do

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ne to solve an existing problem identified by some executive.

Software is used on a continuing

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

basis, serving as both a prognosis and a diagnosis. It is preventive as well as curative medicin

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

e for factoring companies. Defining the information needs is the most important step in the deve

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

lopment of factoring software. The efficacy of the system as a whole depends on this basic step.

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

When clarity is lacking with regard to information needs, the software as a whole gets misdirect

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ed and handicapped. Good software recognizes that different executive levels in the company requ

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ire different types/ segments of information and it ensures that information needs of various ex

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ecutive positions in the company are defined by the concerned executive themselves.

Good softwa

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

re should fulfill the following requirements. It must be unified. It must be conceived and used

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

as a decision support system. It must be compatible with the company and with the overall level

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

of sophistication of the firm. It must be user oriented and it must secure the involvement of us

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ers. It must also involve and motivate the suppliers of the information. It must be economical.

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

The cost value ratio of the information processed by the software should be favorable to the fir

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

m. It must be capable of absorbing smoothly any changes that may become necessary in the system

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.cases.org.ua/article/3689/cases-Factoring-Software.html">Factoring Software</a>

BB link (for phorums):
[url=http://www.cases.org.ua/article/3689/cases-Factoring-Software.html]Factoring Software[/url]

It's got to be perfect - actually it doesn't. 'Good enough' is better. Reluctant salespeople please note.

Working for volunteer organizations and running for office in various non-profits is an excellent way to expose your expertise. But how does this help you work with your Power Team members?

Envelopes are required by nearly all commercial businesses all over the world. Since this product is in such a great demand, no wonder so many are in the business of making envelopes. There are mainly four types of envelopes businesses: manufacturing, supply, printing and inserting.

Tags

Links

Cases - Factoring Software

Related Articles: